vs
Side-by-side financial comparison of Neuphoria Therapeutics Inc. (NEUP) and SIFCO INDUSTRIES INC (SIF). Click either name above to swap in a different company.
SIFCO INDUSTRIES INC is the larger business by last-quarter revenue ($24.0M vs $15.0M, roughly 1.6× Neuphoria Therapeutics Inc.). Neuphoria Therapeutics Inc. runs the higher net margin — 75.1% vs 7.5%, a 67.6% gap on every dollar of revenue.
Neuphoria Therapeutics Inc is a clinical-stage biopharmaceutical company focused on researching and developing innovative targeted therapies for unmet medical needs in neurological and psychiatric conditions, including anxiety, treatment-resistant depression, and other central nervous system disorders. Its core R&D efforts prioritize delivering safer, more effective treatment options for patient groups with limited existing care alternatives.
SIFCO Industries, Inc. (SIFCO), is a global metal component manufacturer based in Cleveland, Ohio.
NEUP vs SIF — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $15.0M | $24.0M |
| Net Profit | $11.3M | $1.8M |
| Gross Margin | — | 21.6% |
| Operating Margin | 79.8% | 10.7% |
| Net Margin | 75.1% | 7.5% |
| Revenue YoY | — | 14.8% |
| Net Profit YoY | — | 177.3% |
| EPS (diluted) | $6.55 | $0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $24.0M | ||
| Q3 25 | — | $22.8M | ||
| Q2 25 | — | $22.1M | ||
| Q1 25 | $15.0M | $19.0M | ||
| Q4 24 | — | $20.9M | ||
| Q3 24 | — | $21.7M | ||
| Q2 24 | — | $22.0M | ||
| Q1 24 | — | $20.5M |
| Q4 25 | — | $1.8M | ||
| Q3 25 | — | $-429.0K | ||
| Q2 25 | — | $3.4M | ||
| Q1 25 | $11.3M | $-1.4M | ||
| Q4 24 | — | $-2.3M | ||
| Q3 24 | — | $-443.0K | ||
| Q2 24 | — | $72.0K | ||
| Q1 24 | — | $-1.6M |
| Q4 25 | — | 21.6% | ||
| Q3 25 | — | 9.6% | ||
| Q2 25 | — | 26.7% | ||
| Q1 25 | — | 8.3% | ||
| Q4 24 | — | 4.4% | ||
| Q3 24 | — | 10.7% | ||
| Q2 24 | — | 12.3% | ||
| Q1 24 | — | 7.3% |
| Q4 25 | — | 10.7% | ||
| Q3 25 | — | -1.7% | ||
| Q2 25 | — | 14.8% | ||
| Q1 25 | 79.8% | -4.1% | ||
| Q4 24 | — | -9.2% | ||
| Q3 24 | — | -1.5% | ||
| Q2 24 | — | 0.7% | ||
| Q1 24 | — | -6.5% |
| Q4 25 | — | 7.5% | ||
| Q3 25 | — | -1.9% | ||
| Q2 25 | — | 15.4% | ||
| Q1 25 | 75.1% | -7.3% | ||
| Q4 24 | — | -11.1% | ||
| Q3 24 | — | -2.0% | ||
| Q2 24 | — | 0.3% | ||
| Q1 24 | — | -7.8% |
| Q4 25 | — | $0.29 | ||
| Q3 25 | — | $-0.07 | ||
| Q2 25 | — | $0.56 | ||
| Q1 25 | $6.55 | $-0.23 | ||
| Q4 24 | — | $-0.38 | ||
| Q3 24 | — | $-0.07 | ||
| Q2 24 | — | $0.01 | ||
| Q1 24 | — | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $17.0M | $1.1M |
| Total DebtLower is stronger | — | $39.0K |
| Stockholders' EquityBook value | $26.0M | $38.7M |
| Total Assets | $30.7M | $74.9M |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.1M | ||
| Q3 25 | — | $491.0K | ||
| Q2 25 | — | $2.0M | ||
| Q1 25 | $17.0M | $1.9M | ||
| Q4 24 | — | $3.1M | ||
| Q3 24 | — | $1.7M | ||
| Q2 24 | — | $3.4M | ||
| Q1 24 | — | $2.5M |
| Q4 25 | — | $39.0K | ||
| Q3 25 | — | $51.0K | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $3.6M | ||
| Q1 24 | — | $4.1M |
| Q4 25 | — | $38.7M | ||
| Q3 25 | — | $36.9M | ||
| Q2 25 | — | $35.8M | ||
| Q1 25 | $26.0M | $32.4M | ||
| Q4 24 | — | $33.7M | ||
| Q3 24 | — | $30.4M | ||
| Q2 24 | — | $29.8M | ||
| Q1 24 | — | $29.7M |
| Q4 25 | — | $74.9M | ||
| Q3 25 | — | $73.4M | ||
| Q2 25 | — | $77.3M | ||
| Q1 25 | $30.7M | $78.8M | ||
| Q4 24 | — | $81.0M | ||
| Q3 24 | — | $104.6M | ||
| Q2 24 | — | $106.3M | ||
| Q1 24 | — | $104.2M |
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 0.14× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.5M | $8.1M |
| Free Cash FlowOCF − Capex | — | $8.0M |
| FCF MarginFCF / Revenue | — | 33.3% |
| Capex IntensityCapex / Revenue | — | 0.4% |
| Cash ConversionOCF / Net Profit | 1.02× | 4.51× |
| TTM Free Cash FlowTrailing 4 quarters | — | $11.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $8.1M | ||
| Q3 25 | — | $726.0K | ||
| Q2 25 | — | $371.0K | ||
| Q1 25 | $11.5M | $2.8M | ||
| Q4 24 | — | $-3.8M | ||
| Q3 24 | — | $857.0K | ||
| Q2 24 | — | $382.0K | ||
| Q1 24 | — | $-3.2M |
| Q4 25 | — | $8.0M | ||
| Q3 25 | — | $566.0K | ||
| Q2 25 | — | $310.0K | ||
| Q1 25 | — | $2.7M | ||
| Q4 24 | — | $-3.9M | ||
| Q3 24 | — | $580.0K | ||
| Q2 24 | — | $-175.0K | ||
| Q1 24 | — | $-3.9M |
| Q4 25 | — | 33.3% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 1.4% | ||
| Q1 25 | — | 14.1% | ||
| Q4 24 | — | -18.8% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | -0.8% | ||
| Q1 24 | — | -18.9% |
| Q4 25 | — | 0.4% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 1.3% | ||
| Q2 24 | — | 2.5% | ||
| Q1 24 | — | 3.3% |
| Q4 25 | — | 4.51× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | 1.02× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 5.31× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NEUP
Segment breakdown not available.
SIF
| Fixed Wing Aircraft Revenue | $10.5M | 44% |
| Commercial Revenue | $8.7M | 36% |
| Commercial Product And Other Revenue | $2.8M | 12% |
| Commercial Space | $1.1M | 5% |
| Other | $840.0K | 4% |
